Methods and applications of serological proteome analysis

Methods in Molecular Biology

Volumn 1061, Issue , 2013, Pages 97-112

  Fulton, Kelly M ^a   Martin, Shannon S ^b   Wolfraim, Lawrence ^b   Twine, Susan M ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b DynPort Vaccine Company LLC   (United States)

Author keywords

Comparative immunoproteomics; Francisella; Immunoproteomics; Live vaccine strain; Serological proteome analysis; SERPA; Tularemia; Western blotting

Indexed keywords

PROTEOME; TULAREMIA VACCINE;

ARTICLE; BLOOD ANALYSIS; IMMUNOBLOTTING; IMMUNOREACTIVITY; ISOELECTRIC FOCUSING; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEROLOGICAL PROTEOME ANALYSIS; SEROLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS; VACCINATION; WESTERN BLOTTING;

BACTERIAL VACCINES; HUMANS; PROTEOME; PROTEOMICS; TULAREMIA; VACCINES, ATTENUATED;

EID: 84884192617     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-589-7_5     Document Type: Article

References (21)

1. Engelfried JJ, Spear F (1966) Modified agglutination test for Pasteurella tularensis. Appl Microbiol 14:267-270
2. Carlsson HE, Lindberg AA, Lindberg G, Hederstedt B, Karlsson KA, Agell BO (1979) Enzyme-linked immunosorbent assay for immunological diagnosis of human tularemia. J Clin Microbiol 10:615-621
3. Bevanger L, Maeland JA, Naess AI (1988) Agglutinins and antibodies to Francisella tularensis outer membrane antigens in the early diagnosis of disease during an outbreak of tularemia. J Clin Microbiol 26:433-437
4. Klade CS (2002) Proteomics approaches towards antigen discovery and vaccine development. Curr Opin Mol Ther 4:216-223
5. Vytvytska O, Nagy E, Bluggel M, Meyer HE, Kurzbauer R, Huber LA, Klade CS (2002) Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis. Proteomics 2:580-590
6. Parida SK, Kaufmann SH (2010) The quest for biomarkers in tuberculosis. Drug Discov Today 15:148-157
7. Kilmury SL, Twine SM (2010) The Francisella tularensis proteome and its recognition by antibodies. Front Microbiol 1:143
8. Eliasson H, Broman T, Forsman M, Back E (2006) Tularemia: current epidemiology and disease management. Infect Dis Clin North Am 20:289-311, ix
9. Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, Lillibridge SR, McDade JE, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Tonat K (2001) Tularemia as a biological weapon: medical and public health management. JAMA 285: 2763-2773
10. Fulton KM, Zhao X, Petit MD, Kilmury SL, Wolfraim LA, House RV, Sjostedt A, Twine SM (2011) Immunoproteomic analysis of the human antibody response to natural tularemia infection with Type A or Type B strains or LVS vaccination. Int J Med Microbiol 301: 591-601
11. Twine SM, Petit MD, Fulton KM, House RV, Conlan JW (2010) Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS). PLoS One 5:e10000
12. Havlasova J, Hernychova L, Brychta M, Hubalek M, Lenco J, Larsson P, Lundqvist M, Forsman M, Krocova Z, Stulik J, Macela A (2005) Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia. Proteomics 5:2090-2103
13. Havlasova J, Hernychova L, Halada P, Pellantova V, Krejsek J, Stulik J, Macela A, Jungblut PR, Larsson P, Forsman M (2002) Mapping of immunoreactive antigens of Francisella tularensis live vaccine strain. Proteomics 2:857-867
14. Janovska S, Pavkova I, Hubalek M, Lenco J, Macela A, Stulik J (2007) Identification of immunoreactive antigens in membrane proteins enriched fraction from Francisella tularensis LVS. Immunol Lett 108:151-159
15. Janovska S, Pavkova I, Reichelova M, Hubaleka M, Stulik J, Macela A (2007) Proteomic analysis of antibody response in a case of laboratoryacquired infection with Francisella tularensis subsp. tularensis. Folia Microbiol (Praha) 52: 194-198
16. Huntley JF, Conley PG, Rasko DA, Hagman KE, Apicella MA, Norgard MV (2008) Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis. Infect Immun 76: 3664-3671
17. Huntley JF, Robertson GT, Norgard MV (2010) Method for the isolation of Francisella tularensis outer membranes. J Vis Exp
18. Kovarova H, Stulik J, Macela A, Lefkovits I, Skrabkova Z (1992) Using two-dimensional gel electrophoresis to study immune response against intracellular bacterial infection. Electrophoresis 13:741-742
19. Macela A, Stulik J, Hernychova L, Kroca M, Krocova Z, Kovarova H (1996) The immune response against Francisella tularensis live vaccine strain in Lps(n) and Lps(d) mice. FEMS Immunol Med Microbiol 13:235-238
20. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
21. Zhao L, Liu C, Sun Y, Ban L (2012) A rapid and simplified method for protein silver staining in polyacrylamide gels. Electrophoresis 33: 2143-2144